Overview
- 69 inspections across 54 sites are on record.
- 140 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2023-05-12.
At a glance
Inspections
69
Sites
54
Observations
140
Career since
Feb 2008
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Quality Packaging Specialists International, LLC | 12 May 2023 | Human Drugs | |
| CHARLES RIVER LABORATORIES | 19 Mar 2020 | Human Drugs | |
| Greenbrier International, Inc | 18 Jan 2019 | Human Drugs | On file |
| Cipla Limited | 13 Apr 2018 | Human Drugs | On file |
| Chartwell Pharmaceuticals Carmel, LLC. | 23 Dec 2013 | Human Drugs | View 483 → |
Sites inspected
Quality Packaging Specialists International, LLCBurlington, United States1 insp.
CHARLES RIVER LABORATORIESWayne, United States1 insp.
Greenbrier International, IncChesapeake, United States1 insp.
Cipla LimitedPithampur, District Dhar, India1 insp.
Chartwell Pharmaceuticals Carmel, LLC.Carmel, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Sony Mathews3 shared
Neil J Bonzagni2 shared
James D Bridges2 shared
Gary J Lehr2 shared
Robert C Steyert2 shared
Juanita P Versace1 shared
Anastasia M Shields1 shared
Nancy F Scheraga1 shared
Patric C Klotzbuecher1 shared
Abby L Mozeke-Baker1 shared
Full investigator report
Get the verbatim findings behind Paul C Mouris' 140 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site